|
MechanismCa2+-ATPases inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Veraverse
0 Patents (Medical) associated with Veraverse
100 Deals associated with Veraverse
100 Translational Medicine associated with Veraverse